Men in Black 3
A sci-fi franchise travels back to 1969.
Directed by Barry Sonnenfeld
(PG-13)
***
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Once Tommy Lee Jones steps aside, Will Smith’s latest big-budget hit is “about as good as one could hope for from an unnecessary sequel,” said Ty Burr in The Boston Globe. Reviving a 15-year-old action-comedy franchise about mismatched secret agents battling aliens in our midst, Smith and Jones only briefly reunite before the “cumbersome” premise sends Smith back to 1969 and unleashes much “deft, absurdist entertainment.” Smith, back from a self-imposed screen hiatus, proves “a reliable pro,” adding nuance to some creaky dialogue and standing back for the two performances that make MIB 3 “actually worth something.” As an alien who can glimpse multiple possible futures at once, “the wonderful Michael Stuhlbarg” wears a perpetually worried smile, said Lisa Schwarzbaum in Entertainment Weekly. As the stand-in for a younger Jones, Josh Brolin creates a riff on the dyspeptic actor that’s “one for the thespian yearbook.” This comedy “manages, in the end, to be touching as well as whimsical,” said A.O. Scott in The New York Times. Maybe it’s because it’s unnecessary that it turns out to be so much fun.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Extremists embrace Musk's salute as Tesla investors fret
IN THE SPOTLIGHT The tech titan insists his Nazi-reminiscent gesture had nothing to do with fascism, even as white nationalists rally around the fascistic salute.
By Rafi Schwartz, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Trump says 25% tariffs on Canada, Mexico start Feb. 1
Speed Read The tariffs imposed on America's neighbors could drive up US prices and invite retaliation
By Peter Weber, The Week US Published